Zostavax Shingles Vaccine Lawsuit
Did you develop shingles after receiving the Zostavax vaccination?
We are here to help.
Our attorneys are investigating claims on behalf clients who developed shingles after receiving the Zostavax shingles vaccination. If you developed shingles anytime between three weeks to one year after receiving the Zostavax vaccine, or were diagnosed with any of the severe conditions listed below within two years of receiving the Zostavax vaccine, please contact us immediately for free consultation.
The lawsuits allege that as a result of the manufacturer’s failure to adequately research the risks associated with the shingles vaccine, and warn about the potential side effects. If you received the Zostavax vaccination and later developed shingles, you may be entitled to financial compensation.
A Brief History of the Zostavax Vaccination
Merck introduced Zostavax in May 2006, as a vaccine for prevention of shingles among older individuals, but it has been linked to reports involving longer and more painful shingles outbreaks. Although the Zostavax shingles vaccine was marketed as safe and effective, increasing evidence suggests that side effects of Zostavax may actual cause the infection it is designed to prevent. The sales data indicates that Zostavax earned Merck as much as over $600 Million each year. It is estimated that the Zostavax shingles vaccine has made Merck billions of dollars.
Shortly after approving the vaccine, the FDA began receiving hundreds, and then thousands, of complaints about Zostavax. The complaints ranged from injection site complications, such as redness and soreness, to vaccine-caused injuries such as shingles, postherpetic neuralgia (permanent nerve damage), necrotizing retinitis (damage to the retina causing vision loss), inner ear damage (resulting in dizziness and hearing loss), and brain and spinal cord nerve damage caused by the vaccine.
The complaints made relating to the Zostavax shingles vaccine caused Merck to add language to the vaccine’s label that cases of shingles and necrotizing retinitis have been reported. This additional language, however, was added too late (2014 and 2016, respectively) after millions were injected with Zostavax. In addition, the new language was wholly inadequate to warn the public of the possibility of injury due to Zostavax.
Zostavax Vaccine May Cause Shingles
Evidence suggests that the Zostavax vaccine is under-attenuated, meaning it is not weak enough, and may pose a serious risk for individuals years after the injection. Before Zostavax was introduced, studies showed that the virus may reactivate on its own, causing individuals who may have never gotten shingles to develop outbreaks due to the live virus in the vaccine.
During the first decade it was on the market, thousands of complaints were filed with the Vaccine Adverse Event Reporting system, included problems with rash, severe skin disease, peripheral neuropathy, cellulitis, myalgia, arthralgia, lymphadenopathy, actinic keratosis, vision loss from herpes keratis, facial paralysis, pneumonia, brain inflammation and other complications.
Zostavax Side Effects
Not only is the Zostavax Shingles Vaccine not very effective in preventing shingles, it can also lead to very serious side effects. Because of this, we are investigating cases where clients developed shingles after receiving the Zostavax vaccination and develop any of the following conditions:
Loss of eyesight
Acute Disseminated Encephalomyelitis (ADEM)
Encephalitis (brain inflammation)
Ramsay Hunt Syndrome
If you developed shingles after receiving the Zostavax vaccine, our attorneys would like to hear from you. Please contact the attorneys at Montgomery Ponder by completing the form on the right-side of this webpage or by clicking here.